Portal Hypertension Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Portal Hypertension Global Clinical Trials Review, H1, 2013" provides data on the Portal Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Portal Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Portal Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Portal Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Portal Hypertension 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Portal Hypertension Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Intercept Pharmaceuticals, Inc. 30
Clinical Trial Overview of Intercept Pharmaceuticals, Inc. 30
Chiasma, Inc. 31
Clinical Trial Overview of Chiasma, Inc. 31
Debiovision, Inc. 32
Clinical Trial Overview of Debiovision, Inc. 32
Dr. Falk Pharma GmbH 33
Clinical Trial Overview of Dr. Falk Pharma GmbH 33
Sucampo Pharmaceuticals, Inc. 34
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 34
Dong-A Pharmaceutical Co., Ltd. 35
Clinical Trial Overview of Dong-A Pharmaceutical Co., Ltd. 35
Aptalis Pharma Inc. 36
Clinical Trial Overview of Aptalis Pharma Inc. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Gilead Sciences, Inc. 38
Clinical Trial Overview of Gilead Sciences, Inc. 38
United Therapeutics Corporation 39
Clinical Trial Overview of United Therapeutics Corporation 39
Clinical Trial Overview of Top Universities / Institutes / Hospitals 40
Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Shandong Provincial Hospital 41
Clinical Trial Overview of Shandong Provincial Hospital 41
Hospital Clinic de Barcelona 42
Clinical Trial Overview of Hospital Clinic de Barcelona 42
Hvidovre University Hospital 43
Clinical Trial Overview of Hvidovre University Hospital 43
Bayside Health 44
Clinical Trial Overview of Bayside Health 44
Medical University of Vienna 45
Clinical Trial Overview of Medical University of Vienna 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
Universita di Bologna 47
Clinical Trial Overview of Universita di Bologna 47
Aga Khan University 48
Clinical Trial Overview of Aga Khan University 48
Govind Ballabh Pant Hospital 49
Clinical Trial Overview of Govind Ballabh Pant Hospital 49
Alexandria University 50
Clinical Trial Overview of Alexandria University 50
Ehime University Graduate School of Medicine 51
Clinical Trial Overview of Ehime University Graduate School of Medicine 51
Royal Prince Alfred Hospital 52
Clinical Trial Overview of Royal Prince Alfred Hospital 52
The Wenzhou Medical College 53
Clinical Trial Overview of The Wenzhou Medical College 53
National Cheng-Kung University Hospital 54
Clinical Trial Overview of National Cheng-Kung University Hospital 54
Fourth Military Medical University 55
Clinical Trial Overview of Fourth Military Medical University 55
Pomeranian Medical University 56
Clinical Trial Overview of Pomeranian Medical University 56
Ghent University Hospital 57
Clinical Trial Overview of Ghent University Hospital 57
University of Alberta 58
Clinical Trial Overview of University of Alberta 58
The University of South Florida 59
Clinical Trial Overview of The University of South Florida 59
Portal Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2013* 39
Portal Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2013* 40
Portal Hypertension Global Clinical Trials Review, H1, 2013 published by GlobalData in January 25, 2013. This report consists of Pages: 83 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
